echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Professor Wang Shumin and Liang Xiaolong's team developed specific fluorescent probes to "light up" lymph node micrometastases in breast cancer

    Professor Wang Shumin and Liang Xiaolong's team developed specific fluorescent probes to "light up" lymph node micrometastases in breast cancer

    • Last Update: 2022-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In February 2022, the team of Pr.


    Breast cancer is one of the malignant tumors with the highest morbidity and mortality among women worldwi.


    Schematic diagram of the construction of MR780 NPs probe and the specific "lighting up" of breast cancer lymph node micrometastases

    Zhao Duo and Xu Menghong, postgraduate students of the Department of Ultrasound Diagnostics, and Yang Shiyuan, a physician of Ultrasound Diagnostics, are the co-first authors of the artic.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.